Although AGFG2 was not associated with AD in 2 major meta-analyses (Jansen et al. 2019; Kunkle et al. 2019), it has recently been identified as being transcriptionally upregulated in AD patients in several independent datasets (Fernandez et al. 2021). The gene discussed is AGFG2; the disease is Alzheimer disease.